Literature DB >> 33942916

Prenatal diagnosis of rhombencephalosynapsis: neuroimaging features and severity of vermian anomaly.

K Krajden Haratz1,2, P Oliveira Szejnfeld3,4,5, M Govindaswamy2, Z Leibovitz6,7,8, L Gindes2,8, M Severino9, A Rossi9,10, D Paladini11, R Garcia Rodriguez12, L Ben-Sira1,2,13, T Borkowski Tillman1, R Gupta14, G Lotem15, N Raz7,16, T E N K Hamamoto17, D Kidron2,18, A Arad2,19, R Birnbaum1,2, M Brussilov1,2, L Pomar20, Y Vial20, R J Leventer21, G McGillivray22, M Fink23, W Krzeszowski24, A Fernandes Moron17, D Lev2,8,25, M Tamarkin2,8, J Shalev2,8,25, J Har Toov1,2, T Lerman-Sagie2,8,26, G Malinger1,2.   

Abstract

OBJECTIVES: To describe the prenatal neuroimaging spectrum of rhombencephalosynapsis (RES) and criteria for its classification according to the severity of vermian anomaly.
METHODS: In this multicenter retrospective study of fetuses with RES between 2002 and 2020, the medical records and brain ultrasound and magnetic resonance images were evaluated comprehensively to determine the severity of the vermian anomaly and the presence of associated brain findings. RES was classified, according to the pattern of vermian agenesis and the extent of the fusion of the hemispheres, as complete RES (complete absence of the vermis) or partial RES (further classified according to the part of the vermis that was missing and, consequently, the region of hemispheric fusion, as anterior, posterior, severe or mixed RES). Findings were compared between cases with complete and those with partial RES.
RESULTS: Included in the study were 62 fetuses with a gestational age ranging between 12 and 37 weeks. Most had complete absence of the vermis (complete RES, 77.4% of cases), a 'round-shaped' cerebellum on axial views (72.6%) and a transverse cerebellar diameter (TCD) < 3rd centile (87.1%). Among the 22.6% of cases with partial RES, 6.5% were classified as severe partial, 6.5% as partial anterior, 8.1% as partial mixed and 1.6% as partial posterior. Half of these cases presented with normal or nearly normal cerebellar morphology and 28.5% had a TCD within the normal limits. Infratentorially, the fourth ventricle was abnormal in 88.7% of cases overall, and anomalies of the midbrain and pons were frequent (93.5% and 77.4%, respectively). Ventriculomegaly was observed in 80.6% of all cases, being more severe in cases with complete RES than in those with partial RES, with high rates of parenchymal and septal disruption.
CONCLUSIONS: This study provides prenatal neuroimaging criteria for the diagnosis and classification of RES, and identification of related features, using ultrasound and magnetic resonance imaging. According to our findings, a diagnosis of RES should be considered in fetuses with a small TCD (severe cerebellar hypoplasia) and/or a round-shaped cerebellum on axial views, during the second or third trimester, especially when associated with ventriculomegaly. Partial RES is more common than previously thought, but presents an extreme diagnostic challenge, especially in cases with normal or nearly-normal cerebellar morphobiometric features.
© 2021 International Society of Ultrasound in Obstetrics and Gynecology. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.

Entities:  

Keywords:  aqueductal stenosis; cerebellum; fetus; prenatal diagnosis; rhombencephalosynapsis; vermis

Mesh:

Year:  2021        PMID: 33942916     DOI: 10.1002/uog.23660

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  2 in total

Review 1.  Fetal Brain Development: Regulating Processes and Related Malformations.

Authors:  Zvi Leibovitz; Tally Lerman-Sagie; Leila Haddad
Journal:  Life (Basel)       Date:  2022-05-29

2.  Applicability of a semiautomated volumetric approach (5D CNS+™) for detailed antenatal reconstruction of abnormal fetal CNS anatomy.

Authors:  Amrei Welp; Michael Gembicki; Christoph Dracopoulos; Jann Lennard Scharf; Achim Rody; Jan Weichert
Journal:  BMC Med Imaging       Date:  2022-09-02       Impact factor: 2.795

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.